NDT Pharmaceuticals Debt 2024

NDT Pharmaceuticals Aktienanalyse

What does NDT Pharmaceuticals do?

NDT Pharmaceuticals Inc is an American company that has been operating in the pharmaceutical industry for over 30 years. It was founded in 1989 by Robert Dickey and is headquartered in New Jersey. The company's focus is on the development and production of prescription drugs, as well as the manufacturing of raw materials for the pharmaceutical industry. The history of NDT Pharmaceuticals Inc dates back to its founding in 1989. Robert Dickey, the company's founder, began his career in the pharmaceutical sector in the 1970s and built his success with The Pharmaceutical Research Institute. This company was later acquired by Pfizer, and in 1989 Dickey joined NDT Pharmaceuticals Inc. At that time, the company had no products and employed only a few people. However, through the dedicated work and innovative ability of Robert Dickey and his team, the company quickly grew and became a major player in the American pharmaceutical market. The business model of NDT Pharmaceuticals Inc is focused on developing prescription drugs and successfully placing them in the market. The company relies on close collaboration with doctors and other medical professionals to best understand and meet the needs of patients. At the same time, the company heavily invests in research and development to stay up to date with the latest medical knowledge and be able to bring innovative products to the market. The company is divided into different divisions to concentrate its focus on various product parameters and meet the needs of patients. These divisions include Hoppliedarkton, which offers products for pain relief and inflammation; Sleepoprofen, which develops and produces medications to support healthy sleep; and Revitalix, which offers products to enhance quality of life based on natural ingredients such as vitamins and antioxidants. Throughout its history, NDT Pharmaceuticals Inc has brought a variety of products to the market aimed at improving health. Some of these products include Naprogesic, a medication for pain treatment during menstruation; Vivenza, an over-the-counter medication for treating sleep disorders; and Revitalift, a highly effective anti-aging complex based on natural plant extracts and vitamins. In conclusion, NDT Pharmaceuticals Inc has established an excellent reputation as a reliable provider of prescription drugs and raw materials for the pharmaceutical industry since its founding. The company relies on close collaboration with medical professionals and a high investment in research and development to develop innovative and effective products. With its different divisions and products, the company aims to improve the health and well-being of its patients. NDT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding NDT Pharmaceuticals's Debt Structure

NDT Pharmaceuticals's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing NDT Pharmaceuticals's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to NDT Pharmaceuticals’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in NDT Pharmaceuticals’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about NDT Pharmaceuticals stock

What is the debt of NDT Pharmaceuticals this year?

NDT Pharmaceuticals has a debt level of 0 USD this year.

What was the debt of NDT Pharmaceuticals compared to the previous year?

The debt of NDT Pharmaceuticals has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in NDT Pharmaceuticals?

High debt can pose a risk for investors of NDT Pharmaceuticals, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of NDT Pharmaceuticals?

Low debt means that NDT Pharmaceuticals has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from NDT Pharmaceuticals affect the company?

An increase in debt of NDT Pharmaceuticals can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of NDT Pharmaceuticals affect the company?

A reduction in debt of NDT Pharmaceuticals can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of NDT Pharmaceuticals?

Some factors that can influence the debt of NDT Pharmaceuticals include investments, acquisitions, operating costs, and revenue development.

Why are the debts of NDT Pharmaceuticals so important for investors?

The debts of NDT Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can NDT Pharmaceuticals take to change the debt?

To change the debt, NDT Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does NDT Pharmaceuticals pay?

Over the past 12 months, NDT Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NDT Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of NDT Pharmaceuticals?

The current dividend yield of NDT Pharmaceuticals is .

When does NDT Pharmaceuticals pay dividends?

NDT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NDT Pharmaceuticals?

NDT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of NDT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is NDT Pharmaceuticals located?

NDT Pharmaceuticals is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von NDT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NDT Pharmaceuticals from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did NDT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of NDT Pharmaceuticals in the year 2023?

In the year 2023, NDT Pharmaceuticals distributed 0 USD as dividends.

In which currency does NDT Pharmaceuticals pay out the dividend?

The dividends of NDT Pharmaceuticals are distributed in USD.